Sarah Joanne Williams
Principal Accounting Officer · AN2 Therapeutics, Inc.
- 2026
- Sep 4, 2026
- 4
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Sarah Joanne Williams files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Robin Shane Readnour - $317K in ANTX purchases and sales in the last 12 months
- Joshua M. Eizen - $53K in ANTX purchases and sales in the last 12 months
- Margaret M. Fitzpatrick - $12K in ANTX purchases and sales in the last 12 months
- Sanjay Chanda - $9K in ANTX purchases and sales in the last 12 months
- Lucy Day - $9K in ANTX purchases and sales in the last 12 months
- Stephen David Prior - $7K in ANTX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Sarah Joanne Williams?
Sarah Joanne Williams is a corporate insider, tracked as Principal Accounting Officer of AN2 Therapeutics, Inc. (ANTX). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Sarah Joanne Williams submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Sarah Joanne Williams been buying or selling stock?
Recorded transactions: 0 open-market purchases and 3 open-market sales ($3K) across all tracked filings.
